Reis, Inc. Declares Quarterly Cash Dividend of $0.17 Per Share
Feb 13, 2017 13:45 pm UTC| Business
NEW YORK, Feb. 13, 2017 -- Reis, Inc.(NASDAQ:REIS) (“Reis” or the “Company”), a leading provider of commercial real estate market information and analytical tools, announced today that on February 10, 2017, its Board of...
Feb 13, 2017 13:34 pm UTC| Business
AUSTIN, Texas, Feb. 13, 2017 -- Xplore Technologies Corp. (NASDAQ:XPLR) today announced that it has fulfilled an initial $1.3 million order for its XSLATE D10 tablet PCs and is in the process of deploying them as part...
Altisource Portfolio Solutions Schedules Fourth Quarter and Full Year Conference Call
Feb 13, 2017 13:32 pm UTC| Business
LUXEMBOURG, Feb. 13, 2017 -- On Thursday, February 16, 2017, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ:ASPS) will report earnings for the fourth quarter of 2016 and full year 2016. A press release and...
Altisource Portfolio Solutions Schedules Fourth Quarter and Full Year Conference Call
Feb 13, 2017 13:32 pm UTC| Business
LUXEMBOURG, Feb. 13, 2017 -- On Thursday, February 16, 2017, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ:ASPS) will report earnings for the fourth quarter of 2016 and full year 2016. A press release and...
Mechel Reports 2016 Operational Results
Feb 13, 2017 13:32 pm UTC| Business
MOSCOW, Russia, Feb. 13, 2017 -- Mechel PAO (MICEX:MTLR)(NYSE:MTL), one of the leading Russian mining and metals companies, announces 2016 operational results. Production and sales for 2016Production:Product...
Mechel Reports 2016 Operational Results
Feb 13, 2017 13:32 pm UTC| Business
MOSCOW, Russia, Feb. 13, 2017 -- Mechel PAO (MICEX:MTLR)(NYSE:MTL), one of the leading Russian mining and metals companies, announces 2016 operational results. Production and sales for 2016Production:Product...
Feb 13, 2017 13:32 pm UTC| Business
41.5% of patients experienced freedom from pain at 2 hours vs. 14.3% for placebo (p 0.0001) 68.3% of patients experienced freedom from most bothersome symptom at 2 hours vs. 42.9% for placebo (p 0.0009) 26.8% of...